Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/5224
Title: Bacteriocin PJ4 Active Against Enteric Pathogen Produced by Lactobacillus helveticus PJ4 Isolated from Gut Microflora of Wistar Rat (Rattus norvegicus): Partial Purification and Characterization of Bacteriocin
Authors: Jena, Prasant Kumar
Trivedi, Disha
Chaudhary, Harshita
Sahoo, Tapasa Kumar
Seshadri, Sriram
Keywords: Faculty Paper
Faculty Paper, Science
Science, Faculty Paper
Lactobacillus helveticus
Bacteriocin
Purification
Characterization
Mode of action
Pathogen
Issue Date: 2013
Publisher: Springer
Abstract: The increase of multidrug-resistant pathogens and the restriction on the use antibiotics due to its side effects have drawn attention to the search for possible alternatives. Bacteriocins are small antimicrobial peptides produced by numerous bacteria. Much interest has been focused on bacteriocins because they exhibit inhibitory activity against pathogens. Lactic acid bacteria possess the ability to synthesize antimicrobial compounds (like bacteriocin) during their growth. In this study, an antibacterial substance (bacteriocin PJ4) produced by Lactobacillus helveticus PJ4, isolated from rat gut microflora, was identified as bacteriocin. It was effective against wide assay of both Gram-positive and Gram-negative bacteria involved in various diseases, including Escherichia coli, Bacillus subtilis, Pseudomonas aeruginosa, Enterococcus faecalis, and Staphylococcus aureus. The antimicrobial peptide was relatively heatresistant and also active over a wide pH range of 2–10. It has been partially purified to homogeneity using ammonium sulfate precipitation and size exclusion chromatography and checked on reverse-phase high-performance liquid chromatography. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis of bacteriocin PJ4 purified through size exclusion chromatography resolved ~6.5 kDa protein with bacteriocin activity. The peptide is inactivated by proteolytic enzymes, trypsin, and lipase but not when treated with catalase, α-amylase, and pepsin. It showed a bactericidal mode of action against the indicator strains E. coli MTCC443, Lactobacillus casei MTCC1423, and E. faecalis DT48. Such characteristics indicate that this bacteriocin may be a potential candidate for alternative agents to control important pathogens
Description: Applled Biochemistry & Biotechnology, 169, 2088–2100
URI: http://hdl.handle.net/123456789/5224
ISSN: 0273-2289
Appears in Collections:Faculty Papers

Files in This Item:
File Description SizeFormat 
2013 Jena et al., 2013a.pdf85765.15 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.